> Details

Cornely, Oliver A; Robertson, Michael N; Haider, Shariq; Grigg, Andrew; Geddes, Michelle; Aoun, Mickael; Heinz, Werner J; Raad, Issam; Schanz, Urs; Meyer, Ralf G; Hammond, Sarah P; Mullane, Kathleen M; Ostermann, Helmut; Ullmann, Andrew J; Zimmerli, Stefan; Van Iersel, M L P S; Hepler, Deborah A; Waskin, Hetty; Kartsonis, Nicholas A; Maertens, Johan

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
  • Contributor: Cornely, Oliver A; Robertson, Michael N; Haider, Shariq; Grigg, Andrew; Geddes, Michelle; Aoun, Mickael; Heinz, Werner J; Raad, Issam; Schanz, Urs; Meyer, Ralf G; Hammond, Sarah P; Mullane, Kathleen M; Ostermann, Helmut; Ullmann, Andrew J; Zimmerli, Stefan; Van Iersel, M L P S; Hepler, Deborah A; Waskin, Hetty; Kartsonis, Nicholas A; Maertens, Johan
  • imprint: Oxford University Press (OUP), 2017
  • Published in: Journal of Antimicrobial Chemotherapy
  • Language: English
  • DOI: 10.1093/jac/dkx382
  • ISSN: 0305-7453; 1460-2091
  • Keywords: Infectious Diseases ; Pharmacology (medical) ; Pharmacology ; Microbiology (medical)
  • Origination:
  • Footnote:
  • Access State: Open Access